Literature DB >> 976606

Plasma renin activity and hypertension in diabetes mellitus.

A R Christlieb, A Kaldany, J A D'Elia.   

Abstract

Plasma renin activity (PRA) was determined in 48 patients with diabetes mellitus in sodium balance on a 10-20 mEq. Na diet. Nine were normotensive (group I), 11 11 were hypertensive without diabetic nephropathy (group III). Results were compared with those in 16 normal subjects and 49 nondiabetic patients with essential hypertension in similar Na balance. Mean supine PRA did not differ significantly among groups I and II, normal subjects, and patients with essential hypertension. Group III diabetics had a supine PRA of 2.4 +/- 0.4 ng./ml./hr. (x +/- S.E.M.), significantly lower than the other diabetic groups (P less than 0.005) and normal subjects (P less than 0.05). Upright PRA was 12.8 +/- 2.2 in group I diabetics, similar to that in normal subjects (13.3 +/- 2.3), and 8.1 +/- 1.4 in group II diabetics, similar to that in essential hypertensives (6.8 +/- 0.8). In group III diabetics, upright PRA was 4.0 +/- 0.5, significantly lower than that in any other group. These results suggest that (1) PRA is normal in normotensive diabetics, (2) upright PRA in diabetics with hypertension but no nephropathy is similar to that in essential hypertension, and (3) patients with diabetes, hypertension, and nephropathy have "low renin hypertension," explaining the virtual absence of malignant hypertension in this group. Although the major mechanism for this low PRA may be volume expansion, indicating the need for potent diuretics, other mechanisms include hyalinization of the afferent arteriole, decreased cathecholamine stimulation of renin release, and inadequate conversion of prorenin to renin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976606     DOI: 10.2337/diab.25.10.969

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  The renin-angiotensin system in blacks: active, passive, or what?

Authors:  Deborah A Price; Naomi D L Fisher
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

2.  Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism.

Authors:  U Kuhlmann; W Vetter; E Fischer; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1978-03-01

3.  Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.

Authors:  Masahiro Eriguchi; Mercury Lin; Michifumi Yamashita; Tuantuan V Zhao; Zakir Khan; Ellen A Bernstein; Susan B Gurley; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

4.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

Authors:  S Björck; G Nyberg; H Mulec; G Granerus; H Herlitz; M Aurell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

5.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

6.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

7.  Blood pressure may be sodium-dependent in diabetic patients without overt nephropathy.

Authors:  J A O'Hare; J B Ferriss; B M Twomey; M Cole; D Brady; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1985-12       Impact factor: 1.568

Review 8.  Angiotensin receptor blockers in diabetic nephropathy.

Authors:  D A Price; N K Hollenberg
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Atrial natriuretic peptide (ANP): a study of ANP and its mRNA in cardiocytes, and of plasma ANP levels in non-obese diabetic mice.

Authors:  H Mifune; S Suzuki; J Honda; Y Kobayashi; Y Noda; Y Hayashi; K Mochizuki
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.